262 related articles for article (PubMed ID: 32284602)
1. Computational design of anti-CRISPR proteins with improved inhibition potency.
Mathony J; Harteveld Z; Schmelas C; Upmeier Zu Belzen J; Aschenbrenner S; Sun W; Hoffmann MD; Stengl C; Scheck A; Georgeon S; Rosset S; Wang Y; Grimm D; Eils R; Correia BE; Niopek D
Nat Chem Biol; 2020 Jul; 16(7):725-730. PubMed ID: 32284602
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1.
Zhu Y; Yin S; Li Z
Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
[TBL] [Abstract][Full Text] [Related]
5. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
6. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
7. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.
Lu B; Javidi-Parsijani P; Makani V; Mehraein-Ghomi F; Sarhan WM; Sun D; Yoo KW; Atala ZP; Lyu P; Atala A
Nucleic Acids Res; 2019 May; 47(8):e44. PubMed ID: 30759231
[TBL] [Abstract][Full Text] [Related]
8. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
Shou J; Li J; Liu Y; Wu Q
Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the anti-CRISPR, AcrIIC4.
Kim GE; Lee SY; Park HH
Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
12. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
13. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y
Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930
[TBL] [Abstract][Full Text] [Related]
14. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
Hoffmann MD; Mathony J; Upmeier Zu Belzen J; Harteveld Z; Aschenbrenner S; Stengl C; Grimm D; Correia BE; Eils R; Niopek D
Nucleic Acids Res; 2021 Mar; 49(5):e29. PubMed ID: 33330940
[TBL] [Abstract][Full Text] [Related]
15. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of Cas9 and single-guided RNAs in
Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
Commun Biol; 2019; 2():161. PubMed ID: 31069270
[TBL] [Abstract][Full Text] [Related]
17. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
18. The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells.
Lee CM; Cradick TJ; Bao G
Mol Ther; 2016 Mar; 24(3):645-54. PubMed ID: 26782639
[TBL] [Abstract][Full Text] [Related]
19. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
20. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
Kim D; Luk K; Wolfe SA; Kim JS
Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
